FlandersBio on Twitter

Follow us on Twitter

new company - News

new company - Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

Cryo-Save launches Africa’s most state-of-the-art cryogenic storage laboratory

31.01.2013

Today, Cryo-Save opens the doors to their state-of-the-art laboratory in Pretoria, the executive capital of South Africa. The newly built laboratory is the most modern facility of its kind in the whole of Africa, and is the largest stem cell storage facility on the continent. It replaces the Cape Town lab. Cryo-Save is the leading family stem cell bank storing more than 225,000 stem cell samples from umbilical cord blood and umbilical cord tissue. read more

Galapagos acquires Cangenix, a structure-based drug discovery company

15.01.2013

Galapagos NV (Euronext: GLPG) and Cangenix Ltd announced today that Galapagos has acquired Cangenix to add structure-based drug discovery to the Argenta service offering. Cangenix's state-of-the-art technology will augment Argenta's ability to design new drugs and fill a growing client need. read more

Galapagos creates Fidelta, a third Galapagos service division

15.01.2013

Galapagos NV (Euronext: GLPG) announced today that the research site in Zagreb, Croatia, will form the basis of a newly created service division, called Fidelta. Next to BioFocus and Argenta, this is the third service division of Galapagos. read more

VIB starts 2013 with launch of new biotech company AgroSavfe

11.01.2013

A strong investment consortium, including ex-reference shareholders from DevGen (Gimv, Madeli Participaties, Biovest), has invested in the new VIB agri-biotech spin-off “AgroSavfe”. Together with Gimv-Agri+, PMV, SOFI, QBIC and VIB, they have invested 5 million EUR in the establishment of the green biotech company that develops innovative technology for sustainable crop protection. read more

ADx NeuroSciences NV enters into exclusive license agreement with K.U.Leuven for the development of antibodies used in dementia diagnosis

07.11.2011

Today the recently founded company ADx NeuroSciences NV entered into a license agreement with K.U.Leuven, the academic founder of ADx NeuroSciences. The license agreement grants ADx NeuroSciences exclusive worldwide rights to further develop and commercialise certain antibodies which selectively bind phosphorylated Tau aggregates. ADx NeuroSciences is a new biotech company that focuses on the development of novel (bio)markers for use in the diagnosis of dementia, such as Alzheimer’s, Parkinson’s and other neurodegenerative diseases. read more

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Back to top

Print